World Wires · story 5316 · unverified · 1 source(s)

Cellectar Biosciences to Present Phase 2 CLOVER WaM Data

Cellectar Biosciences will present Phase 2 data on Iopofosine I 131 in patients with Waldenström Macroglobulinemia at an international workshop.

Open in the desk

Coverage

• Cellectar Biosciences to Present Phase 2 CLOVER WaM Data GlobeNewswire: public companies · tier D · clear net · 2026-09-29 11:30 UTC

What this site indexes